This product is a recombinant mouse antibody clone AD4, which specifically binds to VACV D13.
Figure 1 Screen for murine hybridomas that secret anti-VACV antibodies with an immunofluorescence assay
HeLa cells grown on cover-slips were infected with VACV WR at a MOI of 0.1 to 0.5 PFU/cell for 8 hrs and then analyzed by immunofluorescence with hybridoma culture supernatants as the primary antibodies. The primary antibodies were stained with a Cy3-conjugated goat anti-mouse secondary antibody (red), and the DNA was stained with DAPI (blue). Specificity of the antibody to VACV is indicated by staining of only WR-infected cells, which display viral DNA factories as areas of cytoplasmic DNA staining. Images obtained with 11 representative hybridomas are shown with the hybridoma clone name. Shown in parenthesis is the group that the hybridoma was subsequently categorized into. Arrows point to viral factories (VF), virion-size particles (V) and aggregates (A).
Meng, X., Zhong, Y., Embry, A., Yan, B., Lu, S., Zhong, G., & Xiang, Y. (2011). Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus. Virology, 409(2), 271-279.
Figure 2 Categorization of the hybridomas into 11 groups according to the apparent molecular weight of the precipitated protein
HeLa cells were infected with VACV WR at a MOI of 10 and metabolically labeled with 35S-methionine and -cysteine from 8 to 16 hpi. The cells were lyzed and immunoprecipitated with the hybridoma supernatants and Protein G sepharose. The precipitated proteins were analyzed by SDS-PAGE, and the autoradiographs of representative samples are shown. The results are grouped together according to the size of the precipitated proteins and are shown from the smallest to the largest precipitated proteins. Shown above each lane is the clone name of the hybrdioma whose supernatant was used for the immunoprecipiation. The control immunoprecipitation with DMEM-10 medium is indicated by "–". The group number of the hybridomas is indicated below the lanes.
Meng, X., Zhong, Y., Embry, A., Yan, B., Lu, S., Zhong, G., & Xiang, Y. (2011). Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus. Virology, 409(2), 271-279.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0348CQ-F(E) | Recombinant Mouse Anti-VACV D13 Antibody Fab Fragment (AD4) | ELISA, IP, IF | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0348CQ-S(P) | Recombinant Mouse Anti-VACV D13 Antibody scFv Fragment (AD4) | ELISA, IP, IF | Mouse scFv |
There are currently no Customer reviews or questions for FAMAB-0348CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.